The ADRIE study is an observational study on the clinical relevance of platelet reactivity in aspirin and clopidogrel treated cardiovascular patients.
The ADRIE study is an observational study on the clinical relevance of platelet reactivity in aspirin and clopidogrel treated cardiovascular patients. Main objective: * to determine if platelet reactivity, assessed by specific and non-specific tests, is predictive of ischemic events during the 3-year follow-up. Secondary objectives: * primary outcome in each pre-specified sub-group : patients with coronary artery disease, ischemic stroke or peripheral arterial disease as main qualifying disease at entry, * to determine if platelet reactivity, assessed by specific and non-specific tests, is predictive of bleeding events during the 3-year follow-up, * to investigate potential determinants of platelet reactivity at entry in the study
Study Type
OBSERVATIONAL
Enrollment
771
University Hospital Geneva; Beziers and Monpellier University Hospitals, France
Geneva - Beziers - Montpellier, France
MACE
adjudicating committee
Time frame: prospective follow-up
MACE in pre-specified sub-groups
patients with coronary artery disease, ischemic stroke or peripheral arterial disease as main qualifying disease at entry
Time frame: prospective follow-up
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.